SNAI1 and breast carcinoma: In human epidermal growth factor receptor (HER)-positive human breast cancer BT474 cells, sufentanil, combined with parecoxib, affected essential EMT markers, including a decrease in SNAIL, pushing forward the epithelial phenotype [60] (Table 2).